These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Comparison of oral and intravenous cyclosporine A in kidney transplants. Asokan VS; Sweny P; Varghese Z; Moorhead JF; Fernando ON Transplant Proc; 1987 Feb; 19(1 Pt 2):1717-8. PubMed ID: 3274412 [No Abstract] [Full Text] [Related]
11. Intravenous cyclosporine to induce immunosuppression in cardiac allograft recipients. Macris MP; Frazier OH; Van Buren CT; Duncan JM Transplant Proc; 1988 Jun; 20(3 Suppl 3):311-5. PubMed ID: 3291261 [No Abstract] [Full Text] [Related]
12. Effects on renal function of combined treatment with trimethoprim and cyclosporine A in kidney transplant patients. Berg KJ; Nordby G; Rootwelt K; Djøseland O; Fauchald P; Mehl A; Narverud J; Talseth T Transplant Proc; 1988 Jun; 20(3):413-5. PubMed ID: 3289171 [No Abstract] [Full Text] [Related]
13. [Use of intravenous cyclosporin in the treatment of episodes of irreversible rejection in renal transplantation]. Morales J; Mocarquer A; James E; Aris L; Herrera L; Morales I Rev Med Chil; 1987 Dec; 115(12):1172-5. PubMed ID: 3332925 [No Abstract] [Full Text] [Related]
14. Clinical management of immunosuppressive therapy for cyclosporine-treated recipients of cadaver kidney transplants at one to six months. Feduska NJ; Melzer J; Amend WJ; Vincenti F; Tomlanovich S; Salvatierra O Transplant Proc; 1986 Apr; 18(2 Suppl 1):136-40. PubMed ID: 3515681 [No Abstract] [Full Text] [Related]
15. The case against conversion to azathioprine in cyclosporine-treated renal recipients. Flechner SM; Lorber M; Van Buren C; Kerman R; Kahan BD Transplant Proc; 1985 Aug; 17(4 Suppl 1):276-81. PubMed ID: 3895667 [No Abstract] [Full Text] [Related]
16. Reversible acute renal toxicity by toxic sinergic effect between gentamicin and cyclosporine. Morales JM; Andres A; Prieto C; Diaz Rolòn JA; Rodicio JL Clin Nephrol; 1988 May; 29(5):272. PubMed ID: 3293857 [No Abstract] [Full Text] [Related]
17. The use of low doses of cyclosporine, azathioprine, and prednisone in renal transplantation. First MR; Alexander JW; Wadhwa N; Penn I; Munda R; Fidler JP; Weiskittel P Transplant Proc; 1986 Apr; 18(2 Suppl 1):132-5. PubMed ID: 3515680 [No Abstract] [Full Text] [Related]
18. Cyclosporine pharmacokinetics in the early course of renal transplantation. Albrecht K; Niebel W; Marggraf G; Eigler FW Transplant Proc; 1987 Feb; 19(1 Pt 2):1719. PubMed ID: 3274413 [No Abstract] [Full Text] [Related]
19. De novo occurrence of hemolytic-uremic syndrome in a cyclosporine-treated renal allograft patient. Verpooten GA; Paulus GJ; Roels F; De Broe ME Transplant Proc; 1987 Apr; 19(2):2943-5. PubMed ID: 3551237 [No Abstract] [Full Text] [Related]
20. Management and prevention of cyclosporine nephrotoxicity after renal transplantation: use of low doses of cyclosporine, azathioprine, and prednisone. Simmons RL; Canafax DM; Strand M; Ascher NL; Payne WD; Sutherland DE; Najarian JS Transplant Proc; 1985 Aug; 17(4 Suppl 1):266-75. PubMed ID: 3895665 [No Abstract] [Full Text] [Related] [Next] [New Search]